Latest Releases
U.S. Senator Tina Smith Named Chair of Key Agriculture Subcommittee
WASHINGTON, D.C. [02/16/23]— Today, U.S. Senator Tina Smith (D-Minn.) announced she will serve as Chair of the Senate Subcommittee on Commodities, Risk Management and Trade, which oversees commodities, crop insurance and trade. “When I first got to the Senate, I fought hard for a spot on the Ag Committee so that I could represent and advocate for Minnesota’s diverse ag sector. I take that role very seriously,” said Sen. Smith. “I’m excited about my new role as chair of this subcommittee, which oversees critically important issues to the agriculture industry in Minnesota from crop insurance to trade. As we begin the legislative year and prepare for the Farm Bill, I will push for crop insurance programs that work well for Minnesota farmers and push USDA to do more to open up foreign markets for Minnesota ag products. I look forward to serving in this new role and will continue working to be a strong partner for Minnesota’s ag community.” When she first joined the Senate in 2018, Sen. Smith fought for and secured a spot on the Senate Agriculture Committee because ag is the backbone of Minnesota’s economy. All Minnesotans are impacted by the Farm Bill, and Sen. Smith heard from Minnesotans with backgrounds in farming, rural development, rural health, and nutrition to make sure that all voices were reflected in the final 5-year bill that passed in 2018 after she joined the Ag Committee. That legislation included many provisions that Sen. Smith authored and championed, including improvement to the dairy safety-net
Klobuchar, Smith Resolution Honoring Late Minnesota Senator David Durenberger Passes Senate
WASHINGTON – U.S. Senators Amy Klobuchar (D-MN) and Tina Smith (D-MN) announced that their resolution honoring the late Minnesota Senator David Durenberger passed the Senate with bipartisan support. Klobuchar and Smith delivered remarks on the Senate floor to honor Senator Durenberger. Video of Klobuchar’s floor remarks are available for TV download HERE and for online viewing HERE. Video of Smith’s floor remarks can be found HERE. “Senator David Durenberger was a true public servant and dedicated legislator who was always guided by his devotion to bipartisanship and helping Minnesotans. Through his leadership on the Americans with Disabilities Act, David helped usher in a whole new era of disability rights and changed millions of lives for the better,” said Klobuchar. “Even after David left the Senate, he found new ways to improve people’s lives through his work on health care, his teaching, and his mentorship. Our resolution will honor Senator Durenberger’s remarkable life and legacy of service to our state and country.” “If I had to name one thing that characterized Dave Durenberger, it was his determination to find solutions to the problems that hold people back in their lives, especially problems with health care. He didn’t care whether an idea came from Republicans or Democrats, he cared about whether it would make a difference,” said Smith. “As we mourn the loss of Senator Durenberger, let us take inspiration from his example of a thoughtful, pragmatic, results-oriented politics. Archie and I send all our support to the Durenberger family – may his
U.S. Sen. Tina Smith Announces Comprehensive Bill To Address Skyrocketing Prescription Drug Prices
DULUTH, MN [08/08/18]—U.S. Sen. Tina Smith (D-Minn.) said today that for far too long the health and financial well-being of families in Minnesota and across the country has been harmed by the skyrocketing price of prescription drugs, and she announced plans to introduce legislation designed to hold large pharmaceutical companies accountable for high prices and bring down costs for both consumers and taxpayers. Sen. Smith, a member of the Senate Health Committee, made her announcement at a “Health Care Cost” listening session in Duluth, where she met with local care providers and health experts as well as residents from across
Sen. Tina Smith Urges Trump Administration to Take Immediate Steps to Reunite Children and Families
WASHINGTON D.C. [08/15/18]— U.S. Sen. Tina Smith (D-Minn.) called on the Trump Administration to immediately take action to reunite the over 500 immigrant children still separated from their families. Sen. Tina Smith—along with 16 of her Senate colleagues—stressed to Department of Homeland Security (DHS) Secretary Kirstjen Nielsen how each passing day that DHS fails to reunite separated children with their parents unacceptably traumatizes these children and their families, including causing psychological and physical developmental harms to children. “We call on DHS to take immediate action to locate every deported parent abroad whose separated child remains in government custody,” wrote Sen. Smith
Sen. Tina Smith’s Measure to Support Military Readiness and Conservation Becomes Law
WASHINGTON, D.C [08/16/18]—U.S. Senator Tina Smith’s (D-Minn.) bipartisan effort to fund military readiness and environmental conservation—also supported by her Minnesota colleague Sen. Amy Klobuchar—was recently signed into law by the President. The Readiness and Environmental Protection Integration (REPI) Program helps military facilities across the country, including Minnesota’s Camp Ripley, manage and protect surrounding land to ensure community development does not impede our nation’s military training. Earlier this year, the Army considered reinterpreting the statute that defines a military installation to remove state-owned military facilities, meaning that state-owned National Guard facilities like Camp Ripley would have been unable to receive REPI
Sens. Smith, Warren Raise Questions about Accuracy of Secretary Azar’s Testimony Blaming Pharmacy Benefit Managers for High Drug Prices
WASHINGTON, DC [08/17/18]—Today, U.S. Sens. Tina Smith (D-Minn.) and Elizabeth Warren (D-Mass.) questioned Health and Human Services (HHS) Secretary Alex Azar about his potentially misleading statements during his Senate testimony in which he blamed pharmacy benefit managers (PBMs) and drug distributors for drug manufacturers’ ongoing refusal to meaningfully reduce drug prices. The senators’ letter follows new information obtained from PBMs and drug distributors that directly contradicts the allegations made by Secretary Azar and raises questions about the accuracy of his testimony to Congress. Despite President Trump’s promises that drug companies would voluntarily enact “massive” price cuts, there have been no significant drug price
English